- New FDA-Approved Diabetes Drug Slashes Heart Attack and Stroke Risk SciTechDaily
- Drug for diabetes and kidney disease may also lower heart attack, stroke risks Medical News Today
- Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes Medical Xpress
- Published Data in The Lancet Diabetes & Endocrinology Highlights Unique Efficacy Benefits of Sotagliflozin to Reduce Major Adverse Cardiovascular Events (MACE) Yahoo Finance
- A diabetes, heart failure, and kidney disease EurekAlert
Source link
Related Articles
-
- More than 900 Californians, including 15 children, have died from the flu this season – The Mercury News
- This New Paper About Eating Out of Plastic Containers Is a Bit Terrifying – Futurism
- Measles Outbreak in Texas and New Mexico Sickens Nearly 100 People – The New York Times
